PharmaRadar360

PharmaRadar360

🇺🇸·Aug 27Research

Breaking News: Daraxonrasib Approved for Pancreatic Cancer

Publisher

A
AACR

USA

This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
AACR
Region
USA
Scope
Research
Published
August 27, 2026

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on aacr.org

Leave the platform to read the original full article on the publisher site.

Source: AACR

Scope: Research

Open original article
Breaking News: Daraxonrasib Approved for Pancreatic Cancer | PharmaRadar360